| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Department of Neuropharmacology, Division of Virology The Scripps Research Institute, La Jolla, CA 92037
Although both self- and pathogen-specific T cells can participate in tissue destruction, recent studies have proposed that after viral infection, bystander T cells of an irrelevant specificity can bypass peptide-MHC restriction and contribute to undesired immunopathological consequences. To evaluate the importance of this mechanism of immunopathogenesis, we determined the relative contributions of Ag-specific and bystander CD8+ T cells to the development of CNS disease. Using lymphocytic choriomeningitis virus (LCMV) as a stimulus for T cell recruitment into the CNS, we demonstrate that bystander CD8+ T cells with an activated surface phenotype can indeed be recruited into the CNS over a chronic time window. These cells become anatomically positioned in the CNS parenchyma, and a fraction aberrantly acquires the capacity to produce the effector cytokine, IFN-
. However, when directly compared with their virus-specific counterparts, the contribution of bystander T cells to CNS damage was insignificant in nature (even when specifically activated). Although bystander T cells alone failed to cause tissue injury, transferring as few as 1000 naive LCMV-specific CD8+ T cells into a restricted repertoire containing only bystander T cells was sufficient to induce immune-mediated pathology and reconstitute a fatal CNS disease. These studies underscore the importance of specific T cells in the development of immunopathology and subsequent disease. Because of highly restrictive constraints imposed by the host, it is more likely that specific, rather than nonspecific, bystander T cells are the active participants in T cell-mediated diseases that afflict humans.
This article has been cited by other articles:
|
|
 |
|
  L. Garidou, S. Heydari, P. Truong, D. G. Brooks, and D. B. McGavern Therapeutic Memory T Cells Require Costimulation for Effective Clearance of a Persistent Viral Infection J. Virol., September 1, 2009; 83(17): 8905 - 8915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Touvrey, L. Derre, E. Devevre, P. Corthesy, P. Romero, N. Rufer, and D. E. Speiser Dominant Human CD8 T Cell Clonotypes Persist Simultaneously as Memory and Effector Cells in Memory Phase J. Immunol., June 1, 2009; 182(11): 6718 - 6726. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. E. McCandless, B. Zhang, M. S. Diamond, and R. S. Klein CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis PNAS, August 12, 2008; 105(32): 11270 - 11275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. R. B. Bantug, D. Cekinovic, R. Bradford, T. Koontz, S. Jonjic, and W. J. Britt CD8+ T Lymphocytes Control Murine Cytomegalovirus Replication in the Central Nervous System of Newborn Animals J. Immunol., August 1, 2008; 181(3): 2111 - 2123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Truong and D. B. McGavern A Novel Virus Carrier State to Evaluate Immunotherapeutic Regimens: Regulatory T Cells Modulate the Pathogenicity of Antiviral Memory Cells J. Immunol., July 15, 2008; 181(2): 1161 - 1169. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Sanchez-Ruiz, L. Wilden, W. Muller, W. Stenzel, A. Brunn, H. Miletic, D. Schluter, and M. Deckert Molecular Mimicry between Neurons and an Intracerebral Pathogen Induces a CD8 T Cell-Mediated Autoimmune Disease J. Immunol., June 15, 2008; 180(12): 8421 - 8433. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Galea, M. Bernardes-Silva, P. A. Forse, N. van Rooijen, R. S. Liblau, and V. H. Perry An antigen-specific pathway for CD8 T cells across the blood-brain barrier J. Exp. Med., September 3, 2007; 204(9): 2023 - 2030. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. H. Hogan, D. O. Co, J. Karman, E. Heninger, M. Suresh, and M. Sandor Virally Activated CD8 T Cells Home to Mycobacterium bovis BCG-Induced Granulomas but Enhance Antimycobacterial Protection Only in Immunodeficient Mice Infect. Immun., March 1, 2007; 75(3): 1154 - 1166. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Lauterbach, E. I. Zuniga, P. Truong, M. B.A. Oldstone, and D. B. McGavern Adoptive immunotherapy induces CNS dendritic cell recruitment and antigen presentation during clearance of a persistent viral infection J. Exp. Med., August 7, 2006; 203(8): 1963 - 1975. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ramakrishna, R. A. Atkinson, S. A. Stohlman, and C. C. Bergmann Vaccine-Induced Memory CD8+ T Cells Cannot Prevent Central Nervous System Virus Reactivation. J. Immunol., March 1, 2006; 176(5): 3062 - 3069. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Ling, M. Sandor, M. Suresh, and Z. Fabry Traumatic Injury and the Presence of Antigen Differentially Contribute to T-Cell Recruitment in the CNS J. Neurosci., January 18, 2006; 26(3): 731 - 741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Chen, N. Khanna, S. A. Stohlman, and C. C. Bergmann Virus-Specific and Bystander CD8 T Cells Recruited during Virus-Induced Encephalomyelitis J. Virol., April 15, 2005; 79(8): 4700 - 4708. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
